Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer’s Disease
Table 2
Differentially expressed endogenous metabolites between groups BSTSF and AD and their change trends in all groups.
Abbreviations: BSTSF: Bushen Tiansui Formula; AD: Alzheimer’s disease; Rt (min): retention time; VIP: variable importance; FC: fold change. Fold change was calculated as average relative quantitation obtained from group BSTSF/group AD, and a value less than 1 indicates a decrease in the metabolites of group BSTSF. The levels of potential biomarkers were labeled with “↓” (downregulated) and “↑” (upregulated) ().aChange trend compared with the sham group. bChange trend compared with the AD group.